Losartan potassium and Upper respiratory tract inflammation - a phase IV clinical study of FDA data

Summary:

Upper respiratory tract inflammation is reported as a side effect among people who take Losartan potassium (losartan potassium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Aspirin, and have Hyperuricaemia.

The phase IV clinical study analyzes which people have Upper respiratory tract inflammation when taking Losartan potassium. It is created by eHealthMe based on reports of 50,026 people who have side effects when taking Losartan potassium from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Upper respiratory tract inflammation?

Upper respiratory tract inflammation is found to be associated with 370 drugs and 582 conditions by eHealthMe. Check the latest studies of Upper respiratory tract inflammation.

On Jul, 09, 2026

50,026 people reported to have side effects when taking Losartan potassium.
Among them, 19 people (0.04%) have Upper respiratory tract inflammation.

Could Losartan potassium cause Upper respiratory tract inflammation?

Among these 19 people:

How long have people been on Losartan potassium when they have Upper respiratory tract inflammation? *

What is the gender of people who have Upper respiratory tract inflammation when taking Losartan potassium? *

female: 72.22 %
male: 27.78 %

What is the age of people who have Upper respiratory tract inflammation when taking Losartan potassium? *

What are other drugs people take besides Losartan potassium? *

What are other side effects people have besides Upper respiratory tract inflammation? *

Urinary Tract Infection: 6 people, 31.58%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 5 people, 26.32%
Headache (pain in head): 4 people, 21.05%
Secondary Adrenocortical Insufficiency (inadequate secretion of acth by the pituitary gland): 4 people, 21.05%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 21.05%
Lymphocytic Hypophysitis (inflammation of the pituitary gland): 4 people, 21.05%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 15.79%
Plantar Fasciitis (painful inflammatory process of the plantar fascia): 3 people, 15.79%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 15.79%
Oral Candidiasis (fungal infection of mouth): 3 people, 15.79%

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 8 people, 42.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 31.58%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 5 people, 26.32%
Malignant Melanoma (skin cancer rises from melancytes): 4 people, 21.05%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 21.05%
Multiple Myeloma (cancer of the plasma cells): 2 people, 10.53%
Gastritis - Chronic (long lasting inflammation of stomach): 2 people, 10.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
Iron Overload: 2 people, 10.53%
Lymphoma (cancer that begins in immune system cells): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and have Upper respiratory tract inflammation?

- Check whether Upper respiratory tract inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Losartan potassium:

Losartan potassium (51,511 reports)

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Upper respiratory tract inflammation:

Upper respiratory tract inflammation (370 drugs)

Browse all the conditions that are associated with Upper respiratory tract inflammation:

Upper respiratory tract inflammation (582 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan potassium) and Losartan potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.